{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:37:53Z","timestamp":1774435073053,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012833","name":"Niigata University","doi-asserted-by":"publisher","award":["JP23dk0207060"],"award-info":[{"award-number":["JP23dk0207060"]}],"id":[{"id":"10.13039\/100012833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","award":["JP23wm0425019"],"award-info":[{"award-number":["JP23wm0425019"]}],"id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["3\\u20134"],"award-info":[{"award-number":["3\\u20134"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22H04923"],"award-info":[{"award-number":["22H04923"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23H00414"],"award-info":[{"award-number":["23H00414"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jns.2024.123203","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T06:25:34Z","timestamp":1724912734000},"page":"123203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Long-standing preservation of levodopa response in progressive supranuclear palsy"],"prefix":"10.1016","volume":"466","author":[{"given":"Terunori","family":"Sano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasuku","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norikazu","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Ikeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Takao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jns.2024.123203_bb0005","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1212\/WNL.44.11.2015","article-title":"Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)","volume":"44","author":"Hauw","year":"1994","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2024.123203_bb0010","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00401-022-02479-4","article-title":"Rainwater charitable foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy","volume":"144","author":"Roemer","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2024.123203_bb0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia","volume":"10","author":"Steele","year":"1964","journal-title":"Arch. Neurol."},{"issue":"Pt 6","key":"10.1016\/j.jns.2024.123203_bb0020","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awh488","article-title":"Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson\u2019s syndrome and PSP-parkinsonism","volume":"128","author":"Williams","year":"2005","journal-title":"Brain J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2024.123203_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2024.123203_bb0030","first-page":"853","volume":"32","author":"Hoglinger","year":"2017","journal-title":"Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria, Movement Disord"},{"issue":"3","key":"10.1016\/j.jns.2024.123203_bb0035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/mds.22977","article-title":"What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?","volume":"25","author":"Williams","year":"2010","journal-title":"Movement Disord."},{"issue":"8","key":"10.1016\/j.jns.2024.123203_bb0040","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1111\/ene.15346","article-title":"Protracted course progressive supranuclear palsy","volume":"29","author":"Couto","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2024.123203_bb0045","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/mds.28010","article-title":"Association of Tripartite Motif Containing 11 rs564309 with tau pathology in progressive Supranuclear palsy","volume":"35","author":"Valentino","year":"2020","journal-title":"Movement Disord."},{"issue":"2","key":"10.1016\/j.jns.2024.123203_bb0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(20)30394-X","article-title":"Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study","volume":"20","author":"Jabbari","year":"2021","journal-title":"Lancet Neurol."},{"issue":"16","key":"10.1016\/j.jns.2024.123203_bb0055","doi-asserted-by":"crossref","first-page":"e1648","DOI":"10.1212\/WNL.0000000000200110","article-title":"Autopsy validation of the diagnostic accuracy of (123)I-Metaiodobenzylguanidine myocardial scintigraphy for Lewy body disease","volume":"98","author":"Matsubara","year":"2022","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2024.123203_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000488138","article-title":"Dysphagia causes symptom fluctuations after oral L-dopa treatment in a patient with Parkinson disease","volume":"10","author":"Sato","year":"2018","journal-title":"Case Rep. Neurol."},{"issue":"12","key":"10.1016\/j.jns.2024.123203_bb0065","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Movement Disord."},{"issue":"1","key":"10.1016\/j.jns.2024.123203_bb0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1750-3639.2007.00054.x","article-title":"Progressive supranuclear palsy: pathology and genetics","volume":"17","author":"Dickson","year":"2007","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.jns.2024.123203_bb0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1440-1789.2010.01134.x","article-title":"Early-stage progressive supranuclear palsy with degenerative lesions confined to the subthalamic nucleus and substantia nigra","volume":"31","author":"Sakai","year":"2011","journal-title":"Neuropathology"},{"issue":"1","key":"10.1016\/j.jns.2024.123203_bb0080","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ana.10793","article-title":"Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration","volume":"55","author":"Arai","year":"2004","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2024.123203_bb0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00401-015-1503-3","article-title":"Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau","volume":"131","author":"Taniguchi-Watanabe","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.jns.2024.123203_bb0090","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1212\/01.WNL.0000165960.04422.D0","article-title":"New and reliable MRI diagnosis for progressive supranuclear palsy","volume":"64","author":"Oba","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2024.123203_bb0095","first-page":"479","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), Part II. Standardization of the neuropathologic assessment of Alzheimer's disease","volume":"41","author":"Mirra","year":"1991"},{"issue":"4","key":"10.1016\/j.jns.2024.123203_bb0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.jns.2024.123203_bb0105","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of a beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2024.123203_bb0110","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/mds.29317","article-title":"Clinical diagnostic accuracy of Parkinson\u2019s disease: where do we stand?","volume":"38","author":"Virameteekul","year":"2023","journal-title":"Movement Disord."},{"issue":"2","key":"10.1016\/j.jns.2024.123203_bb0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","article-title":"Distribution patterns of tau pathology in progressive supranuclear palsy","volume":"140","author":"Kovacs","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.jns.2024.123203_bb0120","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1272\/jnms.82.266","article-title":"Early stage of progressive Supranuclear palsy: a neuropathological study of 324 consecutive autopsy cases","volume":"82","author":"Nogami","year":"2015","journal-title":"J. Nippon Med. Sch."},{"issue":"4","key":"10.1016\/j.jns.2024.123203_bb0125","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.25308","article-title":"Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype","volume":"84","author":"Jabbari","year":"2018","journal-title":"Ann. Neurol."},{"issue":"7880","key":"10.1016\/j.jns.2024.123203_bb0130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41586-021-03911-7","article-title":"Structure-based classification of tauopathies","volume":"598","author":"Shi","year":"2021","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.jns.2024.123203_bb0135","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.0000000000201485","article-title":"Progressive supranuclear palsy syndrome associated with a novel tauopathy: case study","volume":"99","author":"Forrest","year":"2022","journal-title":"Neurology"},{"issue":"Pt 3","key":"10.1016\/j.jns.2024.123203_bb0140","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/brain\/awm302","article-title":"Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson\u2019s disease","volume":"131","author":"Orimo","year":"2008","journal-title":"Brain J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2024.123203_bb0145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-510X(97)00278-5","article-title":"Differentiation of idiopathic Parkinson\u2019s disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy","volume":"155","author":"Yoshita","year":"1998","journal-title":"J. Neurol. Sci."},{"issue":"9","key":"10.1016\/j.jns.2024.123203_bb0150","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1253\/jcj.59.599","article-title":"Clinical usefulness of 123I-metaiodobenzylguanidine myocardial scintigraphy in diabetic patients with cardiac sympathetic nerve dysfunction","volume":"59","author":"Miyanaga","year":"1995","journal-title":"Jpn. Circ. J."},{"issue":"7","key":"10.1016\/j.jns.2024.123203_bb0155","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00006231-199207000-00006","article-title":"A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG)","volume":"13","author":"Solanki","year":"1992","journal-title":"Nucl. Med. Commun."},{"issue":"8","key":"10.1016\/j.jns.2024.123203_bb0160","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.clineuro.2013.01.004","article-title":"Autopsy-confirmed progressive supranuclear palsy with decreased uptake of metaiodobenzylguanidine","volume":"115","author":"Adachi","year":"2013","journal-title":"Clin. Neurol. Neurosurg."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24003381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24003381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:05:02Z","timestamp":1741064702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X24003381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":32,"alternative-id":["S0022510X24003381"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.123203","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-standing preservation of levodopa response in progressive supranuclear palsy","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.123203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123203"}}